2017 | The Wall Street Analyzer - Part 19

Latest News

[ May 2, 2025 ] Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results News Feed
[ April 30, 2025 ] Pasofino Gold Announces Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million News Feed
[ April 14, 2025 ] Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks Market News
[ April 11, 2025 ] Canadian Gold Corp. Doubles the Phase 4 Drill Program at Tartan Mine Following McEwen Mining Investment News Feed
[ April 11, 2025 ] Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens News Feed
[ March 25, 2025 ] Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants News Feed
[ March 20, 2025 ] Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview News Feed

No Picture

Neurotrope BioScience (OTCQB:NTRP) CEO Interview

February 1, 2017 The Wall Street Analyzer Comments Off

Interview with Susanne Wilke, CEO […]

No Picture

Gevo, Inc (NASDAQ: GEVO) CEO Interview

January 26, 2017 The Wall Street Analyzer Comments Off

Interview with Patrick Gruber, CEO […]

No Picture

Lexaria Bioscience (OTCQB:LXRP) (CSE:LXX) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Chris Bunka […]

No Picture

Park Place Energy (OTCQB: PKPL) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Scott Larsen […]

No Picture

Tamarack Valley Energy Ltd. (TSX: TVE) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Brian Schmidt, CEO […]

No Picture

Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Marc Voight, CEO […]

No Picture

Aphria, Inc. (TSXV: APH) (OTCQB: APHQF) Management Interview

January 19, 2017 The Wall Street Analyzer Comments Off

Interview with Carl Merton, CFO […]

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) CEO Interview Update

January 18, 2017 The Wall Street Analyzer Comments Off

Interview update with Jeffrey Bacha, CEO […]

No Picture

AudioEye, Inc. (OTCQB: AEYE) CEO INTERVIEW

January 12, 2017 The Wall Street Analyzer Comments Off

Interview with Todd Bankofier, CEO […]

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) CEO Interview

January 9, 2017 The Wall Street Analyzer 1

Interview update with CEO James Sapirstein […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com